The changing pattern of HIV neuropathology in the HAART Era

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 5, 2003, Pages 429-440

  Gray, Françoise ^a,e   Chrétien, Fabrice ^b   Vallat Decouvelaere, Anne Valérie ^c   Scaravilli, Francesco ^d  

^a Université Paris Ile de France Ouest   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Acquired immunodeficiency syndrome (AIDS); Central nervous system; Highly active antiretroviral treatment (HAART); Human immunodeficiency virus (HIV); Neuropathology

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; AUTOPSY; BK VIRUS; BRAIN; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM; CYTOMEGALOVIRUS; DISEASE COURSE; ENCEPHALITIS; FRANCE; HERPES SIMPLEX ENCEPHALITIS; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; NEUROPATHOLOGY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SURVIVAL; TOXOPLASMOSIS;

EID: 0037651991     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.5.429     Document Type: Article

References (52)

1. Hogg RS, O'Shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997;349:1294
2. Bonnet F, Morlat P, Chene G, et al. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med 2002;3:195-99
3. D'Arminio Monforte A, Duca PG, Vago L, Grassi MP, Moroni M. Decreasing incidence of CNS AIDS defining events associated with antiretroviral therapy. Neurology 2000;54:1856-59
4. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry 2000;69:376-80
5. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998;351:1682-86
6. Sacktor N, Lyles RH, Skolasky R, et al. HIV associated neurologic disease incidence changes: Multicenter AIDS cohort study, 1990-1998. Neurology 2001;56:257-60
7. Hoffmann C, Tabrizian S, Wolf E, et al. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 2001;15: 2119-27
8. Albrecht H, Hoffmann C, Degen O, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998;12:1149-54
9. Clifford DB, Yiannoutsos C, Glicksman M, et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 1999;52:623-25
10. Gasnault J, Taoufik Y, Goujard C, et al. Prolonged survival without neurological impairment in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. J Neurovirol 1999;5:241-49
11. Sacktor NC, Lyles RH, Skolasky RL, et al. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 1999;52:1640-47
12. Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol 2000;6:84-88
13. Chang L, Ernst T, leonido-Yee M, et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 1999;53:782-89
14. Dore G, Correll PK, Ly Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999;13:1249-53
15. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002;8:136-42
16. Tozzi V, Balestra P, Galgani S, et al. Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J Acquir Immune Defic Syndr 2001;28:19-27
17. Lambotte O, Deiva K, Tardieu M. HIV-1 persistence, viral reservoir and the central nervous system at the HAART era. Brain Pathol 2003;13: (in press)
18. Kandanearatchi A, Williams B, Everall IP. Assessing the efficacy of highly active antiretroviral therapy in the brain. Brain Pathol 2003;13: (in press)
19. Gea-Banacloche JC, Clifford Lane H. Immune reconstitution in HIV infection. AIDS 1999;13:S25-S38
20. Jellinger KA, Setinek U, Drlicek M, Böhm G, Steurer A, Lintner F. Neuropathology and general autopsy findings in AIDS during the last years. Acta Neuropathol 2000;100:213-20
21. Masliah E, DeTeresa RM, Mallory ME, Hansen LA. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 2000;14:69-74
22. Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K. Autopsy findings in human immunodeficiency virus-infected population over 2 decades: Influences of gender, ethnicity, risk factors and time. Arch Pathol Lab Med 2002;126:182-90
23. Ammassari A, Cingolani A, Pezzotti P, et al. AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 2000;55:1194-1200
24. Gray F, Geny C, Lionnet F, et al. Etude neuropathologique de 135 cas adultes de syndrome d'immunodéficience acquise (SIDA). Ann Pathol 1991;11:236-47
25. Gray F, Gherardi R, Keohane C, Favolini M, Sobel A, Poirier J. Pathology of the Central Nervous System in 40 cases of acquired immune deficiency syndrome (AIDS). Neuropathol Applied Neurol 1988;14:365-80
26. Gray F, Adle-Biassette H, Chrétien F, Lorin de la Grandmaison G, Force G, Keohane C. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Clin Neuropathol 2001; 20:145-55
27. O'Sullivan CE, Drew WL, McMullen DJ, et al. Decrease of cytomegalovirus replication in human immunodeficiency virus-infected patients after treatment with highly active antiretroviral therapy. J Infect Dis 1999;180:847-49
28. Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001;98:3406-12
29. Gates AE, Kaplan LD. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 2002;16:657-65
30. Berger JR, Major EO. Progressive multifocal leukoencephalopathy. Semin Neurol 1999;19:193-200
31. Gray F, Bélec L, Lescs MC, et al. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 1994;117:987-99
32. Tan SV, Guiloff RJ, Scaravilli F, Klapper PE, Graham MC, Gazzard BG. Herpes simplex type 1 encephalitis in acquired immunodeficiency syndrome. Ann Neurol 1993;34:619-22
33. Chrétien F, Bélec L, Hilton DA, et al. Herpes simplex type 1 encephalitis in acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol 1996;22:394-404
34. Nebuloni M, Vago L, Boldorini R, Bonetto S, Costanzi G. VZV fulminant necrotizing encephalitis with concomitant EBV-related lymphoma and CMV ventriculitis: Report of an AIDS case. J Neurovirol 1998;4:457-60
35. Gray F, Bélec L, Keohane C, et al. Zidovudine therapy and HIV encephalitis: A 10-year neuropathological survey. AIDS 1994;8: 489-93
36. Lesprit P, Chaline-Lehmann D, Authier FJ, Ponnelle T, Gray F, Levy Y. BK virus encephalitis in a patient with AIDS and lymphoma. AIDS 2001;15:1196-99
37. Vallbracht A, Löhler J, Gossmann J, et al. Disseminated BK virus type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 1993;143:29-39
38. Bratt G, Hammarin AL, Grandien M, et al. BK virus as a cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 1999;13:1071-75
39. Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus (HIV) infection in the course of syphilis and on the response to treatment. Ann Intern Med 1990;113:872-81
40. Gray F, Alonso JM. Bacterial infections of the central nervous system. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology, 7th edition. London, New York, New Dehli: Arnold, 2002:151-93
41. Langford TD, Letendre SL, Marcotte TD, et al. Severe demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 2002;16:1019-29
42. Cheng VCC, Yuen K-Y, Chan W-M, Wong SSY, Ma ESK, Chan RMT. Immunorestitution disease involving the innate and adaptative response. Clin Infect Dis 2000;30:882-92
43. Foudraine NA, Hovenkamp E, Notermans DW, et al. Immunopathology as a result of highly active antiretroviral therapy in HIV-1 infected patients. AIDS 1999;13:177-84
44. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-45
45. Miralles P, Berenguer J, Lacruz C, et al. Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 2001;15:1900-1902
46. Moulignier A, Authier FJ, Baudrimont M, et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 1997;41: 438-45
47. Gherardi RK, Chrétien F, Delfau-Larue M-H, et al. Neuropathy in diffuse infiltrative lymphocytosis syndrome. An HIV neuropathy, not a lymphoma. Neurology 1998;50:1041-44
48. Authier FJ, Gherardi R. Involvement of the peripheral nerve in the HAART era. Brain Pathol 2003;13: (in press)
49. Strittmatter C, Lang W. Wiestler OD, Kleihues P. The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: A study of 46 postmortem cases. Acta Neuropathol 1992;83:475-81
50. Gray F, Chrétien F, Orlikowsky D, Carlier R. "Burnt out" varicellazoster virus (VZV) encephalitis in an AIDS patients treated by highly active antiretroviral therapy (HAART). (Abstract) Neuropathol Appl Neurobiol 2003; (in press)
51. Scaravilli F, Gray F. Opportunistic infections. In: E Gray, ed. Atlas of the neuropathology of HIV infection. New York, Tokyo, Oxford: Oxford University Press, 1993:49-120
52. Schmidbauer M, Budka H, Shah KV. Progressive multifocal leukoencephalopathy (PML) in AIDS and in the pre-AIDS era. A neuropathological comparison using immunocytochemistry and in situ DNA hybridization for virus detection. Acta Neuropathol 1990;80: 375-80